Duncan McHale

Duncan McHale is a declared insider of Evelo Biosciences, Inc. (senior executive), with filings sourced from SEC (Form 4). We count 6 filings; the first trade dates from 27 May 2022 and the latest from 7 November 2023.

In open-market terms, that means 1 purchase on one side and 1 sale on the other. The totals exclude 2 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 option exercises. Since January 2023: no purchases and 1 sale on the market.

Most recently, on 8 November 2023, the filings show an option exercise in Evelo Biosciences, Inc. The latest purchase dates back some time: it was published 1,601 days ago, on 31 May 2022. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.